Piramal Enterprises Ltd - Company Profile

Powered by

All the data and insights you need on Piramal Enterprises Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Piramal Enterprises Ltd Strategy Report

  • Understand Piramal Enterprises Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Piramal Enterprises Ltd: Overview

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd, is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, Phyto Medicines, Anesthesia, Orthopedic medicines, Halothane, Isoflurane, Sevoflurane, and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, and structured investments. The company serves life sciences, financial services, health care, specialty glass packaging, and real estate sectors. It operates in India Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Gain a 360-degree view of Piramal Enterprises Ltd and make more informed decisions for your business Gain a 360-degree view of Piramal Enterprises Ltd and make more informed decisions for your business Find out more
Headquarters India

Address Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, Maharashtra, 400070


Telephone 91 22 38023000

No of Employees 12,220

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PEL (NSE)

Revenue (2022) $1.1B 6.8% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 418.4% (2022 vs 2021)

Market Cap* $2.3B

Net Profit Margin (2022) XYZ 385.3% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Piramal Enterprises Ltd premium industry data and analytics

60+

Clinical Trials

Determine Piramal Enterprises Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

18+

Pipeline Drugs

Identify which of Piramal Enterprises Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Investigators

Review investigator profiles and find information on trial contacts across Piramal Enterprises Ltd, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Piramal Enterprises Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
Consumer Contract Manufacturing
Phyto Medicines Pharma Solutions
OTC Financial Services
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Piramal Enterprises Ltd portfolio and identify potential areas for collaboration Understand Piramal Enterprises Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In January, the company entered into an agreement to acquire a 10.39% stake in Annapurna Finance Private Limited.
2023 Corporate Changes/Expansions In December, the company opened an antibody-drug conjugate manufacturing facility in Grangemouth, the UK.
2023 Others In March, Piramal Pharma Solutions completed the integrated development and manufacturing of drug substance and drug product for Brenzavvy.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Piramal Enterprises Ltd Sun Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Ltd Cipla Ltd Aditya Birla Sun Life Insurance Company Limited
Headquarters India India India India India
City Mumbai Mumbai Hyderabad Mumbai Mumbai
State/Province Maharashtra Maharashtra Telangana Maharashtra Maharashtra
No. of Employees 12,220 41,000 24,832 26,615 16,800
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ajay G. Piramal Chairman Executive Board 1988 -
Upma Goel Chief Financial Officer Senior Management 2022 -
Vikram Bector President; Chief Human Resources Officer Senior Management - -
Nandini Piramal Director; Head - Over-The-Counter (OTC) business Executive Board 2009 -
Peter DeYoung Chief Executive Officer - Piramal Global Pharma; Director - Piramal Global Pharma Executive Board - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Piramal Enterprises Ltd key executives to enhance your sales strategy Gain insight into Piramal Enterprises Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward